This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1ym1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1ym1.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1ym1.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1ym1| PDB=1ym1 | SCENE= }}
{{STRUCTURE_1ym1| PDB=1ym1 | SCENE= }}
-
'''X-ray crystallographic structure of CTX-M-9 beta-lactamase complexed with a boronic acid inhibitor (SM2)'''
+
===X-ray crystallographic structure of CTX-M-9 beta-lactamase complexed with a boronic acid inhibitor (SM2)===
-
==Overview==
+
<!--
-
CTX-M enzymes are an emerging group of extended spectrum beta-lactamases (ESBLs) that hydrolyze not only the penicillins but also the first-, second-, and third-generation cephalosporins. Although they have become the most frequently observed ESBLs in certain areas, there are few effective inhibitors and relatively little is known about their detailed mechanism. Here we describe the X-ray crystal structures of CTX-M enzymes in complex with different transition-state analogues and beta-lactam inhibitors, representing the enzyme as it progresses from its acylation transition state to its acyl enzyme complex to the deacylation transition state. As the enzyme moves along this reaction coordinate, two key catalytic residues, Lys73 and Glu166, change conformations, tracking the state of the reaction. Unexpectedly, the acyl enzyme complex with the beta-lactam inhibitor cefoxitin still has the catalytic water bound; this water had been predicted to be displaced by the unusual 7alpha-methoxy of the inhibitor. Instead, the 7alpha-group appears to inhibit by preventing the formation of the deacylation transition state through steric hindrance. From an inhibitor design standpoint, we note that the best of the reversible inhibitors, a ceftazidime-like boronic acid compound, binds to CTX-M-16 with a K(i) value of 4 nM. When used together in cell culture, this inhibitor reversed cefotaxime resistance in CTX-M-producing bacteria. The structure of its complex with CTX-M enzyme and the structural view of the reaction coordinate described here provide templates for inhibitor design and intervention to combat this family of antibiotic resistance enzymes.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15826180}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15826180 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15826180}}
==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Deacylation]]
[[Category: Deacylation]]
[[Category: Transition state]]
[[Category: Transition state]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 16:29:45 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 23:24:50 2008''

Revision as of 20:24, 27 July 2008

Image:1ym1.png

Template:STRUCTURE 1ym1

X-ray crystallographic structure of CTX-M-9 beta-lactamase complexed with a boronic acid inhibitor (SM2)

Template:ABSTRACT PUBMED 15826180

About this Structure

1YM1 is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.

Reference

Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases., Chen Y, Shoichet B, Bonnet R, J Am Chem Soc. 2005 Apr 20;127(15):5423-34. PMID:15826180

Page seeded by OCA on Sun Jul 27 23:24:50 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1ym1"
Personal tools